Alnylam Pharmaceuticals (ALNY) led the translation of RNA interference (RNAi) into a new class of innovative therapeutics, transforming the lives of people afflicted with rare and prevalent diseases with unmet needs.
RNAi is a natural cellular process of gene silencing that represents promising and rapidly advancing frontiers in biology and drug . . .
This content is for paid subscribers.
Impacting News May 25, 2022